We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Imaging System Accelerates Research By Streamlining Preclinical Workflow

By Biotechdaily staff writers
Posted on 26 Sep 2007
A new flexible and open system provides a comprehensive solution for imaging analytics that includes complete image processing, quantification, and visualization tools designed for preclinical imaging. More...


The new Preclinical Workspace, developed by Philips Medical Systems (Best, The Netherlands), also features project-centric and hypothesis-driven workflow that supports four modalities: positron emission tomography (PET), computed tomography (CT), single photon computed tomography (SPECT), and magnetic resonance imaging (MRI), and is based on an expandable platform to accommodate current and future preclinical imaging needs. The Workspace can be used in conjunction with Philips' Mosaic HP and NanoSPECT/CT systems for centralized preclinical processing.

During this year's Joint Molecular Imaging Conference sponsored by the Academy of Molecular Imaging (AMI) and the Society of Molecular Imaging (SMI) held in September 2007 in Providence, RI, USA, Philips presented its complete preclinical system range, including a new Preclinical Workspace, the Mosaic HP preclinical PET system with new software version, and the NanoSPECT/CT (available through a distribution agreement with Bioscan, Inc. (Washington DC, USA).

Philips Mosaic HP is equipped with high-performance LYSO detector technology. The dedicated preclinical PET system provides flexibility and efficiency for a wide range of preclinical research applications in oncology, cardiology, and neurology. The system's extra-long imaging bore and long axial field of view allows imaging of a variety of research fields and bio-distribution studies on a whole subject in a single scan. At the AMI/SMI meeting, Philips also launched a new software release for the Mosaic HP that will add several new functionalities and enhancements, such as cardiac gating application in list mode, CT attenuation correction and connectivity to the new Preclinical Workspace.

Another Philips imaging system, the NanoSPECT/CT, helps accelerate preclinical research, the discovery of new, targeted biomarkers, and the development and validation of new molecular diagnostic and therapeutic applications. The system enables fast, dynamic SPECT and dual-isotope imaging with ultra-high sensitivity and sub-millimeter resolution.


Related Links:
Philips Medical Systems

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.